GPX4 and hepatocellular carcinoma: Glutathione reduces Fe(III) to Fe(II) in hepatocellular carcinoma, triggering ferroptosis and breaking down RF@LA-Fe-MOF to release RSL3 and iFSP1, which act as inhibitors of GPX4 and FSP1, respectively.